HCV Core Antigen Screening in Pakistan
Author Information
Author(s): Yousaf Muhammad Z, Idrees Muhammad, Saleem Zafar, Rehman Irshad U, Ali Muhammad
Primary Institution: National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
Can the core antigen of HCV genotype 3a be effectively used as a screening agent for HCV infection in Pakistan?
Conclusion
The developed screening assay is more sensitive, specific, and reproducible than commercially available assays for HCV in Pakistan.
Supporting Evidence
- The assay achieved 100% sensitivity and specificity when tested against a standardized panel of 200 HCV positive and 200 HCV negative sera.
- The developed assay was validated using 120 serum specimens of suspected HCV infection.
- The study demonstrated that the in-house assay is more specific than commercially available assays for HCV strains in Pakistan.
Takeaway
The researchers created a new test to find hepatitis C in people, and it works better than the old tests used in Pakistan.
Methodology
The study involved RNA extraction, cDNA synthesis, PCR amplification, cloning, expression in E. coli, and validation of the screening assay using serum samples.
Limitations
The assay may not detect HCV infection in samples taken before the production of anti-HCV antibodies.
Participant Demographics
The study included serum specimens from individuals suspected of HCV infection across various geographical regions of Pakistan.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website